COMMUNIQUÉS West-GlobeNewswire

Pure Radiance Medispa Introduces Seattle’s First FDA-Cleared, Needle-Free Hair Growth Laser With Zero Downtime
05/01/2026
Non-surgical hormone-safe solution now available for patients seeking stronger, fuller, natural hair growth. Seattle, WA, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Pure Radiance Medispa , one of Seattle’s leading destinations [...]
A Better Life Therapy Joins the Lumina Therapy Alliance, Marking a Major Expansion of the Nation’s Gold Standard for Concierge, In-Person Mental Health Care
05/01/2026
Elizabeth Earnshaw’s nationally recognized Philadelphia practice brings elite clinical leadership, cultural influence, and high-touch care to Lumina’s growing employer-focused network NEW YORK, Jan. 05, 2026 (GLOBE [...]
DentPrime Publishes Comprehensive Patient Guidance Framework for Individuals Considering Dental Treatment Abroad
05/01/2026
Photo: DentPrime via FL Comms. ANTALYA, Türkiye, Jan. 05, 2026 (GLOBE NEWSWIRE) -- DentPrime today announced the publication of a comprehensive patient guidance framework designed to support individuals who are [...]
Zealand Pharma to present at the J.P. Morgan Healthcare Conference
05/01/2026
Press release – No. 1 / 2026 Zealand Pharma to present at the J.P. Morgan Healthcare Conference Copenhagen, Denmark, January 5, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. [...]
Idorsia’s daridorexant in women during menopausal transition age with insomnia
05/01/2026
New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared to placebo in women during menopausal transition age Brigham and Women’s Hospital to study the [...]
Plum Tree Launches 2026 with Expanded Access to Mental Health Care for Children and Adolescents
05/01/2026
ST. CHARLES, Ill., Jan. 05, 2026 (GLOBE NEWSWIRE) -- As families enter the new year, Plum Tree Psychology, a child and adolescent behavioral health practice serving Kane County and surrounding communities, is expanding [...]
SAFE - DEMISSION DE RODOLPHE CADIO ET NOMINATION DE NICOLAS PAPILLON AU CONSEIL D'ADMINISTRATION
05/01/2026
DEMISSION DE RODOLPHE CADIO ET NOMINATION DE NICOLAS PAPILLON AU CONSEIL D'ADMINISTRATION Fleurieux-sur-l’Arbresle – France – 5 janvier 2026 – 18h - Safe (FR001400ZU25 – ALSAF), annonce la démission de Rodolphe Cadio de [...]
Humacyte Announces Planned Marketing Authorization Application for Symvess® in Israel
05/01/2026
- Expansion plans are based on requests for product access received from surgeons and hospitals in Israel - - Expansion of Symvess into other territories, including those in Europe and the Middle East, is also planned [...]
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution
05/01/2026
Clearance would position the Ceribell System as the first and only point-of-care electroencephalography (EEG) technology to aid in detection and monitoring of Large Vessel Occlusion (LVO) stroke in the hospital setting [...]
BlossomHill Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12
05/01/2026
SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. , a privately-held, clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, [...]
LENZ Therapeutics and Lunatus Announce Exclusive Commercialization Partnership for VIZZ™ in the Middle East
05/01/2026
Exclusive distribution agreement includes revenue sharing in addition to upfront and milestone payments to LENZ SAN DIEGO and DUBAI, United Arab Emirates, Jan. 05, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. ( [...]
Compass Therapeutics Announces Key Leadership Appointments
05/01/2026
BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple [...]
HOOPP hits 500,000-member milestone, strengthening retirement security for Ontario’s healthcare community
05/01/2026
Half a million futures. One pension promise. TORONTO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan has surpassed the 500,000-membership mark, an important milestone that reflects HOOPP’s [...]
Permanent J Code for ZUSDURI™ Now in Effect, Expanding Patient Access to Innovative Bladder Cancer Therapy
05/01/2026
PRINCETON, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today [...]
Kyverna Therapeutics to Present at the J.P. Morgan 2026 Healthcare Conference
05/01/2026
EMERYVILLE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune [...]
Crinetics Announces Strong PALSONIFY Launch Execution and Positive Results for Concurrent Androstenedione Lowering and Glucocorticoid Dose Reduction in Phase 2 Trial of Atumelnant for Congenital Adrenal Hyperplasia
05/01/2026
Strong PALSONIFY U.S. Launch Execution Resulted in Unaudited and Preliminary Net Product Revenue of >$5 Million for Fourth-Quarter 2025, with >200 Enrollment Forms at the End of December Atumelnant (80 mg) [...]
Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials
05/01/2026
-- Interim data from 14 patients with progressive lung cancers in dose-escalation cohorts of systemically administered Olvi-Vec-primed immunochemotherapy across ongoing SCLC and NSCLC trials; enrollment ongoing – -- In [...]
Protara Therapeutics Receives Both FDA Breakthrough Therapy and Fast Track Designations for TARA-002 in Pediatric Patients with Lymphatic Malformations
05/01/2026
TARA-002 selected for FDA manufacturing development and readiness pilot program NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative [...]
Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT™ XR in the Journal of Clinical Endocrinology and Metabolism
05/01/2026
REDWOOD CITY, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced a [...]

Pages